Clinical Outcomes Of Infectious Scleritis: An Analysis Of 17 Year Data From A Referral Cornea Service
Published 2023 - 41st Congress of the ESCRS
Reference: PP06.10 | DOI: 10.82333/j8yg-0g12
Authors: Aravind Roy* 1 , Somasheila Murthy 2 , Joveeta Joseph 3
1Shantilal Sanghvi Cornea Institute,L V Prasad Eye Institute, KVC Campus,Vijayawada,India, 2Shantilal Sanghvi Cornea Institute,L V Prasad Eye Institute, KAR Campus,Hyderabad,India, 3Jhaveri Microbiology Laboratory,L V Prasad Eye Institute, KAR Campus,Hyderabad,India
To study the aetiology, predisposing factors, and management outcomes of infectious scleritis.
Hospital based cohort study
Retrospective chart review of 82 eyes of 82 patients with infectious scleritis in a tertiary cornea service between January 2005 to December 2021.
Demographics include male predominance(n=65), agricultural workers (n=37), associated systemic disease (n=35), history of ocular surgery or antecedent trauma(n=45) on prior medications(n=41). Chief complaints were watering, redness and pain between 1 day to 6 months(n=68). Visual acuity of < 20/200 at presentation and last follow up was 61 vs. 53, (p 0.17). Microbiology included; bacteria 57, fungus 13, acanthamoeba 4, and mixed infection 8. Odds of concomitant corneal (n=37) compared to vitreo-retinal involvement(n=14) was 2.46 (95% CI 1.32-5.25, p0.0056). Common surgical procedures performed include scleral deroofing(n=44), patch graft/keratoplasty(n=18). All except 11 eyes were eviscerated. Mean duration of treatment was 7.41±9.39 weeks.
Infectious scleritis is a chronic ocular infection. There is a significant chance concomitant keratitis. Intensive antimicrobial treatment and early surgical debridement can salvage eyes.